Professor Luiz Moutinho (BA, MA, PhD, MAE, FCIM) is Visiting Professor of Marketing at the Faculty of Arts, Business and Applied Social Science, University of Suffolk, Ipswich, UK. In 2020 he was elected a member of the Academia Europaea, and in 2017 he received the title of Professor Honoris Causa from the University of Tourism and Management Skopje, North Macedonia. In 2025 he was ranked among the top 85 of the 100 best scientists in Business and Management by Research.com and listed in the top 0.05% of global scholars in Marketing and Management by ScholarGPS. From 2015 to 2017, he served as Professor of BioMarketing and Futures Research at DCU Business School, Dublin City University—the world’s first chair covering both fields. Prior to this, he held the Foundation Chair of Marketing at the Adam Smith Business School, University of Glasgow, for 20 years. He completed his PhD at the University of Sheffield in 1982 and has been a Full Professor for 36 years, with academic posts at Cardiff Business School, Cleveland State University, Northern Arizona University, and California State University. He has also held Visiting Professorships in China, Lithuania, Austria, New Zealand, Denmark, Slovenia, Portugal, Hungary, Taiwan, Brazil, Colombia, Fiji and Cyprus. Professor Moutinho directed doctoral programmes at the Confederation of Scottish Business Schools, Cardiff Business School, and the University of Glasgow. He is the Founding Editor-in-Chief of the Journal of Modelling in Management and Co-editor-in-Chief of Innovative Marketing, serving on the editorial boards of 47 journals. His research spans marketing futurecast, AI, biometrics, neuroscience, evolutionary algorithms, consumer behaviour modelling, and tourism futurecast. He has delivered keynote addresses in 64 countries and has published 41 books and over 163 refereed journal articles.

Dr. Chris Stout is a licensed clinical psychologist and international humanitarian with a diverse background in various domains. He is the Founding Director of the Center for Global Initiatives (a Top-Rated Nonprofit) and is the Executive Producer and Host of the popular “Living a Life in Full” a top-ranked podcast with an audience of over 3 million. He was a Fellow in the School of Public Health and Full Professor in the Department of Psychiatry in the College of Medicine at the University of Illinois, Chicago and prior to that he held an academic appointment at Northwestern University’s Feinberg School of Medicine. He served as a NGO Special Representative and had the honor of speaking at the United Nations; he holds the distinction of being one of only 100 world-wide leaders appointed to the World Economic Forum’s Global Leaders of Tomorrow and was an Invited Faculty at the Annual Meeting in Davos. Dr. Stout is a worldwide speaker, organizational consultant and startup whisperer having worked or traveled in all 50 states, over 100 countries and 6 continents. He was noted as being “one of the most frequently cited psychologists in the scientific literature.” He is a Fellow in the American Psychological Association, past-President of the Illinois Psychological Association, and is a Distinguished Practitioner in the National Academies of Practice. He is a Best-Selling Author, having published 38 books. His works have been translated into 8 languages. He is a recipient of four Humanitarian Awards and four additional honorary doctorates. He is a popular LinkedIn Top Voice nearing a half-million followers and has been a guest on CNBC, CNN, NBC, PBS, NPR, and Oprah. He was listed in Fast Co.’s Global Fast 50 nominees and in TED Founder Richard Saul Wurman’s “Who’s Really Who.” His professional archive was deeded to the Smithsonian’s Museum for the History of Psychology. He balances all his academic and humanitarian efforts with time with his family, adventure sports, and mountaineering (having climbed 3 of the world’s 7 Summits).

Jahnavi Kachhia is an Global Product Owner, AI & ML specializing in scalable, production-grade intelligent systems. Her work focuses on translating advanced machine learning research into real-world, high-impact applications, with emphasis on trustworthy and responsible AI. She has contributed to large-scale AI-driven platforms, including LLM-based intelligent systems and complex distributed technologies. Jahnavi serves on the Program Committees of IJCAI (2025, 2026) and PAKDD (2026), reviews for leading AI conferences, and has peer-reviewed publications in IEEE Xplore and Hindawi spanning deep learning, signal processing, and applied AI systems.

Ify Nwiwu is a qualified and accomplished Registered Nurse, holding both RNLD and RGN registrations. She is a PhD researcher at the University of Wolverhampton, where her work focuses on the lived experiences and healthcare implications of Female Genital Mutilation (FGM) and Breast Ironing (BI). Ify graduated with a First-Class degree in Learning Disability Nursing and later completed a master’s degree in Adult Nursing, both from the University of Wolverhampton. She is a multi-award-winning researcher, recognised at several national and international academic conferences for her work on FGM and BI. These accolades include recognition from institutions such as the University of Cambridge, Leeds Beckett University, and the University of Wolverhampton, among others. In addition, Ify has published a number of articles focusing on women’s health, women’s rights, cultural practices, and advocacy for vulnerable and marginalised groups. With a diverse professional background, Ify has worked extensively within the NHS as a Health Facilitation Nurse and a Mental Health Practitioner with CAMHS, as well as in the private healthcare sector. Her clinical, academic, and leadership experience informs her holistic and person-centred approach to care. Ify is currently a Lecturer in Learning Disability Nursing at the faculty of Health Sciences and Wellbeing at the University of Sunderland in London. She is deeply committed to advocacy for women and vulnerable children, using her own lived experience to inspire and empower others. Having pursued her education as an adult learner, she is particularly passionate about encouraging women to return to education, build confidence, and develop the skills to advocate for themselves and their communities. Her work reflects a strong commitment to social justice, equality in healthcare, and the advancement of culturally competent, trauma-informed practice.

Marco Carotenuto, MD, PhD, is Full Professor of Child and Adolescent Neuropsychiatry at the University of Campania “Luigi Vanvitelli” (Italy). His clinical and research activity focuses on pediatric sleep disorders, neurodevelopmental conditions (ASD, ADHD), neuroinflammation, and translational sleep neurobiology. He has authored more than 300 peer-reviewed publications and serves in editorial roles for international journals in pediatric neurology and sleep medicine. Professor Carotenuto’s research integrates polysomnography, sleep microstructure (including CAP analysis), inflammatory biomarkers, and executive functioning assessment to characterize multidimensional sleep phenotypes in children. His work explores the interaction between glymphatic physiology, immune signaling pathways, and cortical regulatory dynamics. He is currently developing biologically grounded models of Persistent Regulatory Cortical Activation (PRCA) to explain sleep instability across neurodevelopmental conditions and to support individualized diagnostic and therapeutic strategies in pediatric populations.

Dr. Bernd Blobel studied Mathematics, Technical Cybernetics and Electronics, Bio-Cybernetics, Physics, Medicine and Informatics at the University of Magdeburg and other universities in the former GDR. He received his PhD in Physics with a neurophysiological study. Furthermore, he performed the Habilitation (qualification as university professor) in Medicine and Informatics. He was Head of the Institute for Biometrics and Medical Informatics at the University of Magdeburg, and thereafter Head of the Health Telematics Project Group at the Fraunhofer IIS in Erlangen. Thereafter, he acted until his retirement as Head of the German National eHealth Competence Center as well as Head of the globally unique International Interdisciplinary PhD and PostDoc College at the University of Regensburg. He was and is still leadingly involved in many countries health digitalization as well as electronic health record strategy. He published more than 600 papers, published/edited many books and supervised a big number of PhD students from all around the world. He was German Representative to many SDOs such as HL7, ISO, CEN, OMG, IEEE, ASTM, SNOMED, etc., also chairing the national mirror groups. Furthermore, he still engaged in international higher education. He is Fellow of several international academies and played specific roles in global organizations such as WHO, European Commission, UNESCO, etc. He is also Visiting Professor at the Charles University in Prague. His extended publication list is available at https://epub.uni-regensburg.de/view/people/Blobel=3ABernd=3A=3A.html.

Dr. Lloyd Tran is the Chairman and Chief Executive Officer of Biomed Industries, Inc., a leading biotechnology company dedicated to developing breakthrough treatments for neurodegenerative and metabolic diseases. Dr. Tran has over 30 years of experience in pharmaceutical research and development, specializing in treatments for neurodegenerative diseases, metabolic disorders, and infectious diseases. He began his career as a scientist at G.D. Searle (later acquired by Monsanto) and Pfizer before serving as Director of Research & Development at Controlled Release Technology, Inc. Dr. Tran served as the Chief Scientific Officer for Biomed Pharmaceutical, Inc, and NeuroActiva, Inc. which was acquired by Biomed Industries, Inc. A pioneer in Alzheimer’s disease research, Dr. Tran was the first to identify the role of neurogenesis in its treatment. He holds multiple U.S. and international patents covering drugs targeting Alzheimer's disease, major depressive disorder, stroke, Rett syndrome, obesity, and Metabolic dysfunction-associated steatohepatitis (MASH). Dr. Tran has also contributed to global health initiatives, collaborating with Nobel laureate Dr. Tu Youyou in the development of Artemether for malaria treatment. Artemether plus lumefantrine (AL) is now approved in the U.S. and 86 countries worldwide. Additionally, he is the inventor of the MICROS Infusion System, which has been approved for marketing in the U.S. Beyond his scientific contributions, Dr. Tran serves as the Committee Chair of the Alzheimer’s International Society and has played a key role in advancing Alzheimer’s research. He holds a B.Sc. (Honours) in Chemistry from the University of Otago and a Ph.D. in Medicinal Chemistry from the University of Wellington, New Zealand.

Prof. Michel Lagarde is a distinguished University Professor Emeritus at INSA-Lyon (Université de Lyon) and an internationally recognized expert in biochemistry, lipidomics, and human biology. He earned his Doctorates in Biochemistry, Sciences, and Human Biology from Claude Bernard University, Lyon, and completed advanced research training through postdoctoral and sabbatical programs in London, Chicago, Michigan State University, and the University of California San Diego. Throughout his remarkable scientific career, Prof. Lagarde served as Head of an INSERM Unit, President of several international scientific societies including GERLI, ICBL, and ISSFAL, and founder of the Institute for Multidisciplinary Biochemistry of Lipids (IMBL). He also co-led multiple international collaborative research initiatives in lipidomics and metabolic sciences. Prof. Lagarde has contributed extensively to scientific leadership as Vice-President of INSA-Lyon, Scientific Director of the LISA Carnot Institute, and President of the International Scientific Advisory Board of the LipSTIC Labex. His pioneering work in lipid science and metabolism has earned him numerous prestigious distinctions, including the Normann Medal, Chevreul Medal, European Lipid Science Award, ISSFAL Fellow recognition, and the Alexander Leaf Lifetime Achievement Award. He is a member of the New York Academy of Sciences and the Académie des Sciences, Belles-Lettres et Arts de Lyon, where he also served as President. His contributions continue to influence global research in lipid biochemistry, nutrition, metabolism, and human health.

Professor Wang is a Boya Distinguished Professor at Peking University, Deputy Dean of the Institute of Advanced Clinical Medicine, and Vice Director of the Neuroscience Research Institute. She currently serves as President of the Chinese Association for Physiological Sciences (CAPS) and First Vice President of the Federation of the Asian and Oceanian Physiological Societies (FAOPS). Her research focuses on cellular signal transduction in the nervous system, integrating multidisciplinary approaches including molecular biology, biochemistry, genetics, electrophysiology, morphology, and behavioral analysis. Her work centers on two major areas: (1) mechanisms of pain and its modulation, using chronic pain models to investigate plasticity in peripheral and central pathways and kinase-mediated signaling underlying pain, emotion, and memory; (2) neurodevelopment, neural injury and repair, and neuropsychiatric disorders, exploring key molecular mechanisms of neuronal polarity, migration, synapse formation, and regeneration. Her studies aim to identify therapeutic targets for neurological and psychiatric diseases. Professor Wang has published more than 80 peer-reviewed articles and holds 10 patents in China. She has received several honors, including the Program for Outstanding Young Teachers in Higher Education Institutions (Ministry of Education), the Hsiang-Tung Chang Young Scientist Award in Neuroscience, and the Wuzhou Women Science & Technology Award from the China Medical Women’s Association.

Dr. Frederick Wittke is a physician, clinical researcher, and former Executive Medical Director at MSD, where he led vaccine clinical development across Europe (2016–2025). With more than 25 years of experience spanning Novartis, GSK, Debiopharm, and MSD, he has driven global Phase I–III programs in vaccines, antimicrobials, maternal immunization, and infectious diseases. His work includes leadership of major pneumococcal, HPV, varicella, and Group B streptococcus vaccine trials, as well as development of the first‑in‑class anti‑staphylococcal antibiotic afabicin. Dr. Wittke has authored over 80 scientific publications and lectures internationally on vaccine development, AMR, and clinical trial science. He is a Visiting Professor at Tel Aviv University and Principal Co-founder of Arthama GmbH, an online learning platform for Clinical development Science focusing on the clinical development of vaccines.

Giorgio Piracci is an Italian ecologist, regenerative systems practitioner and interdisciplinary researcher working at the intersection of ecology, complexity science and traditional knowledge systems. He holds Master's degrees in Environmental and Natural Resources Conservation, and International Cooperation for Rural Development and has over twenty years of international experience designing and leading regenerative agriculture, sustainability and ecosystem restoration programmes across Europe, Latin America and Africa for multinational companies, NGOs and local communities. His professional journey has progressively evolved from regenerative ecology toward the investigation of adaptive living systems across multiple scales—from ecosystems and organizations to human physiology and cognition. His current work focuses on developing an integrative theoretical framework exploring whether biological, ecological, psychological and social regeneration may represent different expressions of common adaptive organizational dynamics. As CEO of Sachakuna, a regenerative retreat center in the Peruvian Amazon and an emerging interdisciplinary Living Laboratory, Giorgio is fostering collaborations between neuroscientists, physicians, ecologists and Indigenous knowledge holders to investigate human adaptation, neuroplasticity, functional coherence and regenerative processes under ecologically valid conditions. His current research interests include regenerative systems, complexity science, traditional ecological knowledge, performance improvement and the development of new conceptual frameworks capable of bridging contemporary science with ancestral knowledge systems. His long-term objective is to contribute to a new interdisciplinary science of adaptive living systems that may inform neuroscience, ecology, economics, organizational leadership and regenerative development.

Dr. Raed Z. Mualem, Ph.D., LL.B., M.Sc., M.A., M.H.A. is a researcher and academic leader specializing in Educational Neuroscience, Eco-Neurobiology, and brain development. He serves as Head of the Eco-Neurobiology Research Group at Oranim Academic College and is a Research Fellow at the Edmond J. Safra Brain Research Center for the Study of Learning Disabilities, University of Haifa, Israel. Dr. Mualem's research focuses on the interaction between environmental, educational, and biological factors that influence cognitive performance, emotional well-being, executive functions, and resilience across the lifespan. His work integrates neuroscience with education to develop evidence-based interventions involving physical activity, music, nutrition, sleep, mindfulness, and supportive learning environments to enhance brain development and academic achievement. He has authored numerous peer-reviewed publications and has presented his research at leading international conferences. Dr. Mualem also leads collaborative initiatives aimed at advancing innovative educational practices and translating neuroscience research into practical applications for schools and communities.

Marco Carotenuto, MD, PhD, is Full Professor of Child and Adolescent Neuropsychiatry at the University of Campania “Luigi Vanvitelli” (Italy). His clinical and research activity focuses on pediatric sleep disorders, neurodevelopmental conditions (ASD, ADHD), neuroinflammation, and translational sleep neurobiology. He has authored more than 300 peer-reviewed publications and serves in editorial roles for international journals in pediatric neurology and sleep medicine. Professor Carotenuto’s research integrates polysomnography, sleep microstructure (including CAP analysis), inflammatory biomarkers, and executive functioning assessment to characterize multidimensional sleep phenotypes in children. His work explores the interaction between glymphatic physiology, immune signaling pathways, and cortical regulatory dynamics. He is currently developing biologically grounded models of Persistent Regulatory Cortical Activation (PRCA) to explain sleep instability across neurodevelopmental conditions and to support individualized diagnostic and therapeutic strategies in pediatric populations.

Jahnavi Kachhia is an Global Product Owner, AI & ML specializing in scalable, production-grade intelligent systems. Her work focuses on translating advanced machine learning research into real-world, high-impact applications, with emphasis on trustworthy and responsible AI. She has contributed to large-scale AI-driven platforms, including LLM-based intelligent systems and complex distributed technologies. Jahnavi serves on the Program Committees of IJCAI (2025, 2026) and PAKDD (2026), reviews for leading AI conferences, and has peer-reviewed publications in IEEE Xplore and Hindawi spanning deep learning, signal processing, and applied AI systems.

Prof. Giuseppe Scalabrino is an internationally recognized Italian physician-scientist and Professor Emeritus of General Pathology at the University of Milan. He earned his M.D. with honors from the University of Milan in 1968 and subsequently built a distinguished academic and research career spanning more than five decades. Throughout his tenure at the University of Milan, he served in numerous leadership roles, including Director of the Institute of General Pathology and Scientific Coordinator of the PhD Program in Experimental Pathology and Neuropathology. Prof. Scalabrino’s scientific contributions have significantly advanced the fields of neurobiology, neuropathology, oncology, and molecular medicine. His early research focused on polyamine metabolism and cancer biology, while his later work pioneered new insights into the neurotrophic functions of vitamin B12 (cobalamin) and its role in the central nervous system. His studies have provided important evidence linking vitamin B12 deficiency to neurological disorders, myelin damage, neuroinflammation, and multiple sclerosis. An invited speaker at numerous international conferences across Europe, North America, and Asia, Prof. Scalabrino has authored more than 90 influential scientific publications and reviews. His research has been widely cited and featured in leading textbooks of neurology, hematology, and neuroscience. He has served on the editorial boards of numerous international journals and has been recognized with prestigious honors, including the International “Röntgen” Award from the Accademia dei Lincei for his contributions to oncological research. Today, Prof. Scalabrino is regarded as a leading authority in neuroscience and vitamin B12-related neurobiology, with a lasting impact on both experimental and clinical research.

Dr. Smita Guha is a Full Professor at St. John’s University in the School of Education. She is the Chairperson of the Department of Curriculum and Instruction. She received her Ph.D. from State University of New York at Buffalo. She is a professor of teacher education in the STEM area. She has over ten years of experience working with children and over 28 years of experience teaching in higher education. To build foundation in teacher education, her current research focuses on child development and cultural perspective. She has authored four books: Today’s Youth, Tomorrow’s Leaders and Healthy Children, Teachers as Researcher and Critical Literacy for Socio-emotional learning. Her articles have been published in peer reviewed scholarly journals. She presented at numerous conferences at International, National, State and Regional levels. Recently, she was awarded Faculty Leadership and Service award from St. John’s university, Proclamation from The Assembly State of New York, Citation from New York State Assembly as Outstanding Individual and Fulbright US Scholar award: Academic and Professional Fellowship.

Dr. Angus B. Gordon is a distinguished British breast surgeon who graduated from St. Bartholomew's Hospital, London, in 1968. He spent many years as a member of the Breast Unit at the Royal Marsden Hospital, Chelsea, before being appointed as a Consultant Breast Surgeon at Charing Cross Hospital in 2006. Throughout his career, he has specialized in breast disease management and has been involved in advancing surgical techniques, including sentinel node biopsy. Mr. Gordon is also an inventor and patent holder, with innovations in sterile vacuum wound drainage systems and tumor volume measurement devices. He has presented his work at leading international meetings, including the Association of Breast Surgeons and the San Antonio Breast Cancer Symposium, contributing significantly to the field of breast cancer diagnosis and treatment.

Dr. Robert Schmidt is a serial entrepreneur, inventor, professional engineer, attorney, and patent attorney. He is the Founder and Chairman of five high-tech companies based in Cleveland, OH, including Orbital Research, Great Lakes NeuroTechnologies, and NeuroWave Systems. His innovations span across defense technologies, neuromonitoring for Parkinson’s Disease, and EEG-based anesthesia systems. Schmidt serves as National Co-Chair of the Small Business Technology Council and is a Trustee of the National Small Business Association. He is also an Advisory Board Member of US Inventor and a member of the IEEE-USA Intellectual Property Committee. Recognized as a leader in innovation, Schmidt received the 2013 Gold Electrode Award as the “Most Valuable Financial Professional” in the neurotech industry. He has led two companies to the Inc. 500 list and has been honored with multiple business growth awards, including the Inc. Inner City 100 (7 times), Weatherhead 100 (15 times), and SBIR Person of the Year (2015). He is listed in Marquis Who’s Who and honored on the National Aviation and Space Exploration Wall of Honor.

Professor Ashok K. Chakraborty, PhD, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process. After earning a Bachelor of Science from the University of Calcutta (India), Dr. Chakraborty earned a master's degree from the same institution. He subsequently received a PhD in Pigment Cell Biology, breast cancer, and melanoma metastasis research through the University of Calcutta in 1980. Over the course of his career, he parlayed his expertise to others as an invited lecturer at Japanese universities (Kobe), and as a research scientist and associate professor at Yale University, where he worked between 1989 and 2014 on Melanoma Biology, Pigment Cell Biology and Breast Cancer Drug Discovery. Supported by his extensive experience, Dr. Chakraborty presently excels as a senior research analyst for AllExcel Inc. Over the years, he has contributed to more than 130 publications, including in Cancer Drug Discovery, Virology, and Neuro-degenerative diseases. He has published his work in peer-reviewed medical journals of the American Association for Cancer Research, Melanoma Research and Breast Cancer Research and Treatment, Elsevier Publications, PLoS one, and in Nature. In order to remain aware of changes in the field, Dr. Chakraborty is affiliated with the Pan-American Society and the Dermatological Society and American Cancer Society. He is also the regular reviewer of several science journals, and in the Editorial Board of various peer-reviewed journals. While his career has been filled with highlights, he is most proud to have joined AllExcel, where he is working on neurodegenerative diseases, including Parkinson's Disease and Alzheimer's Disease, and also drug discovery for COVID-19, and Cancer. Since joining the organization, he has reprogrammed neural stem cells non-genetically and transplanted them into a rat PD model, which helped to revert disease symptoms and cognition defects. In the wake of the COVID-19 pandemic, he also began working on a new polymer-based nano-micelles antiviral regiment, which showed its dual activity to combat disease. Most of these works were already published as a Review and/or as a Research article in more than 20 peer-reviewed journals including Frontiers, Elsevier Publications. Besides the above he is also teaching Chemistry of Nutrition as a Professor of Chemistry at the Sacred heart University. He has already published 20 papers on Nutrition and its Importance on disease management. Looking toward the future, Dr. Chakraborty intends to conduct a clinical trial for a Parkinson's disease treatment, as well as macrophage polarization for cancer treatment.

Richard A. Lawhern, PhD is the Founder & Principal Speaker Emeritus of the National Campaign to Protect People in Pain (USA) and a nationally recognized subject matter expert in public health policy, pain medicine, and addiction medicine. His distinguished career spans more than six decades of public service across military, aerospace, and healthcare sectors. Dr. Lawhern served 21 years in the United States Air Force, retiring as a Lieutenant Colonel (Colonel Select) in 1988. He subsequently spent 22 years as a senior systems engineer and technology futurist in the U.S. aerospace industry. For more than three decades, he has dedicated his efforts to advancing evidence-based public health policy, with a particular focus on improving the regulation of pain management and addiction medicine. He has authored or co-authored over 400 scientific papers, journal articles, policy publications, and media interviews, contributing extensively to discussions on pain care, opioid policy, and patient advocacy. Through his leadership with the National Campaign to Protect People in Pain, Dr. Lawhern continues to advocate for balanced healthcare policies and improved access to compassionate, evidence-based pain management. His expertise bridges public policy, clinical practice, and patient advocacy, making him a respected voice in the fields of pain medicine, healthcare education, and public health.

Dr. Ricardo Rojas Bedoya is a Peruvian neuroscientist, consciousness researcher, educator, and international lecturer with more than five decades of dedicated research into the nature of the brain, mind, and consciousness. He is the Founder and Director of the World Institute for the Science of Consciousness, the founder of Neuronoetics, and the creator of Noesian Pedagogy. Throughout his distinguished career, Dr. Rojas has been devoted to understanding how the brain, mind, and consciousness interact in the emergence and development of the human being. His work integrates neuroscience with contemplative practices, neurofeedback, Transcendental Meditation, pharyngeal breathing, and his original iSYS Model—a conceptual framework that maps the dynamic relationships among brain, mind, consciousness, identity, and human transformation. In collaboration with entrepreneur Abraham Carranza, CEO of IAM Mastermind, Dr. Rojas also designs and leads immersive retreats in Tarapoto, Peru, where neuroscience, self-awareness, neurofeedback, body-based regulation, and experiential learning converge to promote personal and cognitive transformation. Renowned for bridging scientific inquiry with lived human experience, Dr. Rojas brings a unique interdisciplinary perspective to the field of consciousness studies, combining rigorous neuroscience with experiential teaching and human development.

Dr. Berne is Graduated in Medicine from the Universidad Michoacana de San Nicolás de Hidalgo with honors. Postgraduate in Neurosurgery at Centro Médico Nacional Siglo XXI IMSS. First place nationally in the certification exam of the Mexican Council of Neurological Surgery. Fellowship at the Instituto de Ciencias Neurológicas de Sao Paulo. Member and invited national and international professor of the Mexican Society of Neurological Surgery, American Association of Neurosurgery, Latin American Federation of Neurosurgery Societies, and World Federation of Neurosurgery. Pastpresident of the Scientific Committee of the XXVII Mexican Congress of Neurological Surgery, Mérida 2003.Member of the Spinal Surgery Committee of FLANC. CEO of NEUROCEREBRI Morelia-Mexico.Assistant, professor, and coordinator of 40 regional congresses, 50 national, and 50 international congresses, as well as instructor of 30 workshops in multiple forums.

Prof. Dr. Gulsen Meral graduated from Istanbul University Cerrahpasa Faculty of Medicine in 1994. She became a Pediatrician in 2001 and served as a specialist physician, deputy chief physician, and chief physician at various hospitals. She completed her doctorate in Medical Genetics at Biruni University. She holds a master's degree in Hospital Management and a bachelor's degree in Turkish Language and Literature. She served as Advisor to the Rector at Northern Cyprus ITU between 2019 and 2021. She has taught Nutrigenetics at the postgraduate level and has taught both undergraduate and postgraduate courses in child development. She is also an acupuncture instructor. She currently serves as a professor in the Department of Child Health and Diseases at Istanbul Nisantası University. She also continues her research and educational activities as the founder and manager of Epigenetic Coaching (UK). Prof. Meral has numerous national and international scientific publications and has served on editorial boards and as a reviewer for various academic journals. In addition to her scientific work, Prof. Meral is also interested in literature and has published five poetry books. She is the founder of the Nutrigenetics and Epigenetics Association in Turkey and the UK and is a member of Yeşilay, the Rumeli Association, the Istanbul Acupuncture Association, and the International Nutrigenetics and Nutrigenomics Association. He has chaired the First, Second, and Third International Epigenetics Congresses and continues to provide leadership and training in the Epigenetics Coaching Program. Additionally, She delivers internationally accredited Continuing Professional Development (CPD) training in Nutrigenetics and Epigenetics Consulting to healthcare professionals worldwide.

Lieutenant Commander Akeeka S. Davis, RN, MSN-Ed, MBA, BSN, CLSSGB (Ret.), United States Navy Nurse Corps, is a distinguished nurse scientist, educator, and healthcare leader with over 30 years of military and healthcare service. She is currently a PhD candidate at Villanova University, where her research focuses on neurocognitive science, nursing education, neurodivergent learners, and health equity. Throughout her career, she has held leadership roles in nursing informatics, healthcare analytics, diversity initiatives, and clinical education within the U.S. Navy and Defense Health Agency. Her work integrates neuroscience, cognitive optimization, and evidence-based educational strategies to improve outcomes for nursing students and healthcare professionals. Her interdisciplinary expertise and dedication to integrating neuroscience, cognitive science, and evidence-based educational strategies continue to contribute significantly to advancing healthcare education, neurodiversity support, and student success initiatives.

Dr. Meltem Uzun, MD, is a Specialist in Pediatric Neurology, Pediatrics, and Child Health with extensive clinical and academic experience in pediatric neurological disorders. She graduated from Uludağ University Faculty of Medicine and completed her Pediatrics residency at Çukurova University, followed by subspecialty training in Pediatric Neurology at Uludağ University. Dr. Uzun has served as a Pediatric Neurology Specialist and Consultant at several leading hospitals in Türkiye, including Konya Training and Research Hospital and Bursa Dörtçelik Children’s Hospital. Her expertise includes epilepsy, neurogenetics, neurometabolic disorders, ketogenic diet therapies, neurodevelopmental disorders, and EEG monitoring. She has also completed advanced international training programs and observerships in epilepsy, movement disorders, neurogenetics, and pediatric neurology at prestigious institutions in Italy, Canada, Japan, and the United States. In recent years, Dr. Uzun expanded her practice into Functional Medicine and Epigenetic Counseling, integrating multidisciplinary approaches into pediatric and adult neurological care. She is an active member of several international professional societies, including EPNS, ILAE, ISS, and AOCNA. Dr. Uzun regularly participates in national and international scientific meetings and has delivered numerous presentations and lectures in her fields of expertise.

Dr. Jennifer Fraser holds a PhD in Comparative Literature from the University of Toronto where she was trained to take different discourses out of their silos, put them in the arena, and see if the conversation changed. When you put neuroscience into the arena with workplace culture, normalized bullying and gaslighting, productivity and profitability, health and wellness, the conversation changes significantly. Fraser's work focuses on what she calls the "Neuroplastic Advantage" that galvanizes us to harness our brains' capacity to change and become sculptors of a better world. Fraser's track record as an award-winning educator, founder of The Bullied Brain, and author of five books infuses her international presentations.

Diana I. Simeonova, Dipl-Psych, PhD is a globally educated and trained European-American clinical and business psychologist. She holds joint appointments as a faculty member at the Emory University School of Medicine, Emory Healthcare, Emory Brain Health Center, and Emory University Goizueta Business School in Atlanta, Georgia, USA. Dr. Simeonova's diverse integrative approach and rich global experiences as a clinician-scientist, executive coach, leadership consultant, entrepreneur, creative innovator and trailblazer inform all aspects of her professional identity and activities. Prior to joining the faculty at Emory, she worked internationally in a number of industries in Bulgaria, Finland, Germany, and The Netherlands. More recently, Dr. Simeonova has worked in clinical, research, and business settings in Germany at the University of Hamburg and the University Medical Center Hamburg-Eppendorf and in the United States at San Francisco State University, Stanford University School of Medicine, Stanford University Department of Psychiatry and Behavioral Sciences, and Stanford University Department of Psychology. She was also a founding partner and business proprietor of a center for comprehensive mental health care and clinical research for children, adolescents, adults, and families, and her team received funding from the pharmacutical industry and conducted randomized controlled trials to evaluate the efficacy and safety of new medications as well as new indications for FDA-approved medications. Dr. Simeonova is the recipient of a number of prestigious career development and travel awards, her research is published in high impact peer-reviewed journals, and her research lab has been funded by the National Institute of Mental Health (NIMH), National Institute of Child Health and Human (NICHD), the Brain and Behavior Research Foundation, and private foundations. She collaborates on a number of research projects as a task group member of the National Network of Depression Centers (NNDC), a non-profit system of 26 leading clinical and academic Centers of Excellence in the USA. Dr. Simeonova's clinical, evaluation, and psychological assessment work has been focused on children, adolescents, adults, families, and women's mental health. As faculty member at the Emory University Goizueta Business School, Dr. Simeonova collaborates with colleagues on leadership development and executive coaching projects, provides consulting and coaching to executives and business leaders, and teaches and coaches in the MBA and Executive MBA programs, the Delta Leadership Development Coaching Fellows Program, the IMPACT Coaching Fellows Program, and Emory Executive Education. Dr. Simeonova's focus is on women in business and executive women in leadership. She is a co-founder and faculty member and has served in several leadership capacities in the Executive Coaching Diploma Program, an International Coaching Federation-accredited coaching training program. Dr. Simeonova' s dynamic global pursuits to date span the gamut of entrepreneurship, from founding and leading a mountain guiding agency to healthcare business ventures and to intellectual, research, social entrepreneurship initiatives and executive coaching/leadership development innovative programs. More information on Dr. Simeonova's background, professional activities, and publication list is available at https://med.emory.edu/directory/profile/?u=DSIMEON

Dr. Nyree Penn, DHSc, CAA, is a NeuroRestorative Sleep Scientist, inventor and the Founder and CEO of NSOMNIA Sleep. With a Doctor of Health Science degree and a background as a Certified Anesthesiologist Assistant, she brings an anesthesia-informed perspective to the distinction between sedation and restorative sleep. Dr. Penn created the NeuroRestorative Sleep framework, the Sleep Independence Blueprint assessment, the NIRA AI sleep coach, and the eight-week Sleep Independence Program. Her work examines the “restoration gap” that can remain when sleep interventions prioritize unconsciousness without adequately addressing sleep architecture, nervous-system safety, ritual, and trust. She is also a Founding Strategic Programming Partner for International Wellness Week 2027, where the NeuroRestorative Sleep Experience will be featured. Her work advances a forward-looking framework for moving beyond sedation-centered approaches and toward restorative sleep.

Professor Wang, Doctoral Supervisor, is a talent introduced under Sun Yat-sen University’s “Hundred Talents Program,” a Category B Special Appointment of the Shenzhen Peacock Plan, a jointly appointed professor at the Southern Marine Science and Engineering Guangdong Laboratory, a core member of the Intelligent Marine Unmanned Equipment Innovation Team, and a member of the Guangdong Provincial Key Laboratory of Sea-Air-Space Communications. He Lead the Multi-Domain Unmanned Systems Cooperative Cognitive Control Technology Laboratory. And he received his bachelor’s, master’s, and doctoral degrees from Northwestern Polytechnical University, Beihang University, and Xi’an Jiaotong University, respectively. His research mainly focuses on situational awareness and cognition for intelligent unmanned systems, advanced guidance, planning, decision-making and control technologies, and multidisciplinary interdisciplinary applied basic research on recognitive intelligence for unmanned systems. He formerly worked at the China Academy of Launch Vehicle Technology (CALT), where he was long engaged in the overall design and research of flight vehicle guidance, navigation, and control (GNC) systems. He has published a total of 67 high-level international journal papers and domestic and international conference papers, been granted 35 invention patents, and formulated one industry association group standard. As the first contributor, he has received five provincial/ministerial-level science and technology awards, including the Special Prize of the Technological Invention Award of the China General Chamber of Commerce Science and Technology Award, the Second Prize of the Technological Invention Award of the Chinese Association of Automation, and the Invention and Entrepreneurship Award of the China Association of Inventions. He has organized or chaired special forums and delivered thematic reports at many international and domestic conferences, including the 1st/2nd National Conference on Large Models and Decision Intelligence, the 6th Manned Spaceflight Academic Conference, the International Low-Altitude Industry Conference, the International Conference on Autonomous Unmanned Systems (ICAUS 2023/2024/2025), and the Conference on Cognitive Computing and Decision Intelligence (CCHI2025). He serves as a member of professional committees of several societies, including the Chinese Association of Automation, the Chinese Institute of Command and Control, the Chinese Society of Astronautics, and the China Society of Image and Graphics."

Albin Kaelin is the founder, owner and CEO of epeaswitzerland gmbh since its foundation in 2009 and has driven the development and implementation of the Cradle to Cradle® design concept and Digital Product Passport Compass Cradle to CradleTM in various areas of industry. As early as 1993, he initiated the development of the Climatex® product line, which produced the world's first Cradle to Cradle® products. Cradle to Cradle® design creates recyclable products by setting itself apart from conventional recycling and maintaining the quality of the raw materials over several product life cycles. All materials are considered nutrients and are used in defined cycles at the right time and in the right place. Author “From Rebel to Radical Innovator; Leading the Transformation through Circularity” Albin Kaelin

Alexandra Macare, M.Ed., is an educator, school leader, curriculum developer, consultant, author, and founder of Always Meaningful Education (AME), with nearly three decades of experience in education. She holds multiple master’s degrees and graduate-level credentials in School Leadership, Literacy, and Applied Educational Neuroscience. Her work sits at the intersection of neuroeducation, cognitive science, human development, and learning design. Drawing on decades of observation and practice, and subsequently refined through research, she developed the Always Meaningful Education (AME) framework, a neuroscience-informed model for creating learning environments that support meaningful, durable, and increasingly self-directed learning. At the foundation of the framework are four conditions: Safety, Connection, Relevance, and Agency. Alexandra’s work examines how these conditions interact with attention, motivation, self-regulation, memory, metacognition, and learner agency, and how educators can translate this understanding into the design of everyday learning environments. She has worked internationally with educators, schools, families, and learning communities, helping connect research with the realities of teaching and learning across diverse contexts. She is also the author of the forthcoming book The Shift, Redesigning Education for New Era of Human Flourishing, which explores how education can move beyond inherited models of schooling toward learning environments designed around human development, curiosity, agency, and how people actually learn. Her work is guided by a central question: How can we create conditions that allow learning not simply to occur, but to endure, transfer, and increasingly belong to the learner?

Tanzila Shaikha is a metabolic health practitioner, speaker, and educator specialising in insulin resistance, hormonal dysfunction, and chronic metabolic disease in women. Her work focuses on the intersection between metabolism, endocrine health, and long-term disease prevention, with particular expertise in conditions such as PCOS, type 2 diabetes, fatty liver, and obesity. Through her clinical education platforms and speaking engagements, she translates complex metabolic science into practical prevention strategies, helping individuals and healthcare professionals better understand the systemic impact of insulin resistance on hormonal, cardiovascular, and neurological health. Her approach emphasises early metabolic intervention as a cornerstone for preventing chronic disease and improving quality of life. She is passionate about advancing awareness of the metabolic roots of modern health challenges and empowering women worldwide to take control of their long-term health outcomes.

Dr. Pradeep V. Mahajan is a Maharashtra Bhushan Award winner and a distinguished leader in regenerative medicine and advanced cellular therapies. He is a Diplomat of the American Board of Regenerative Medicine (USA) and holds an extensive medical background, including MBBS, MS (General Surgery), AFIH, and a Diploma in Urology from Austria. He serves as Adjunct Assistant Professor of Surgery in the Division of Plastic Surgery at the Indiana School of Regenerative Medicine, Indiana University, USA, and as Honorary Professor of General Surgery at Terna Medical College and Hospital, Navi Mumbai. He is also Faculty and Director for the MUHS Fellowship Course in regenerative medicine and an examiner for stem cell courses at D.Y. Patil Medical College, Kolhapur. Dr. Mahajan is widely recognized for his pioneering contributions to transformational healthcare, particularly through the development and application of regenerative medicine and cellular therapy technologies where conventional treatments have limitations. He has introduced several innovative technology-based treatments, including Mitochondrial Delivery Interphase (MDI), for which he has received specialized training. He has extensive clinical experience in treating degenerative medical conditions using MDI and has published and spoken widely on the subject. In collaboration with Sheba Medical Center, Dr. Mahajan is actively working to bring CAR-T cell therapy and advanced smart technologies to India, aiming to make cutting-edge cancer treatments affordable and accessible. A sought-after keynote speaker, Dr. Mahajan has presented at prestigious global platforms, including the World Gene Convention Conference (Osaka, Japan), Stem Cell Conference (UK), and several international medical conferences. He has published 37 research papers and holds a national patent for Avascular Necrosis, with multiple other patents under regulatory review. He also serves as a peer reviewer for reputed international medical journals.

Codrina Ancuța is a leading Romanian rheumatologist, serving as Professor of Rheumatology at the prestigious “Grigore T. Popa” University of Medicine and Pharmacy of Iași - one of the oldest and most respected medical schools in Romania, Consultant in Rheumatology, and Head of the 2ndRheumatology Department at the Clinical Rehabilitation Hospital. She graduated from the same university in 1994, obtained her specialization in Rheumatology in 1999 and in Rehabilitation Medicine in 2001, defended her PhD in Internal Medicine on the challenging topic of rheumatoid myositisin 2005, and completed her habilitation in 2019 with a thesis entitled “Insights and Perspectives in Immune-Mediated Rheumatic Disorders.” With more than two decades of experience, she has combined clinical excellence with academic leadership, also coordinating the EUSTAR (European Scleroderma Trials and Research) Center 162 in Iași. Professor Ancuța has acted as principal investigator or team member in over 90 randomized controlled trials, reflecting her strong engagement in advancing evidence-based therapies. She has authored numerous ISI-indexed publications, with significant contributions to the understanding and management of biological therapies in rheumatoid arthritis, spondyloarthropathies, and autoimmune rheumatic diseases such as lupus, systemic sclerosis, and Sjögren’s syndrome. She is also frequently invited by major pharmaceutical companies as an expert lecturer and scientific advisor, contributing to educational programs, symposia, and professional training activities in rheumatology at both national and international levels. Her professional mission is to improve patient outcomes, inspire the next generation of clinicians, and foster innovation in rheumatology through compassionate care, rigorous research, and academic excellence.

Dr. Surbhi Kaura is a Professor of Physiotherapy at Galgotias University, India, with over 13 years of academic, clinical, and research experience in neurological rehabilitation. She holds a PhD in Physiotherapy, with specialized research expertise in neuromodulation and spinal cord injury (SCI) rehabilitation. Her academic and clinical work focuses on translating emerging neurorehabilitation technologies into meaningful improvements in functional recovery. Her doctoral research has focused on epidural spinal cord stimulation combined with rehabilitation for individuals with spinal cord injury, with experience in individualized stimulation approaches, motor recovery, postural control, functional mobility, autonomic outcomes, longitudinal clinical assessment, and clinical trial coordination. Dr. Surbhi has developed international academic and clinical exposure through an international clinical observer-ship in neuromodulation at Liv Bona Dea International Hospital, Azerbaijan, where she gained experience in contemporary neuromodulation practices and multidisciplinary patient management. She has also presented research related to neuromodulation and rehabilitation at international conferences in Dubai and Indonesia, receiving academic bursaries. Her broader academic interests include neural recovery, brain–spinal cord interactions, neuroplasticity, technology-assisted rehabilitation, and interdisciplinary neuroscience research. She is particularly interested in collaborative research that bridges laboratory neuroscience, neuromodulation, and real-world clinical rehabilitation. These experiences have strengthened her commitment to international collaboration and global academic engagement.

Dr. Nagaraj Halemani is a medical doctor, neuroscientist, and precision medicine researcher with over 20 years of experience spanning clinical practice, neuroscience research, and global medical affairs. He is the Founder and Consultant at the iBrains Centre for Precision Neuropsychiatry in Bengaluru, India, where he leads the development of AI-driven precision medicine approaches for the early detection, risk prediction, and personalized management of neuropsychiatric disorders. Dr. Halemani earned his Ph.D. in Neuroscience through the Max Planck Institute for Biophysical Chemistry and the University of Bonn, Germany, following an M.Sc. in Molecular Genetics from the University of Leicester, UK, and an M.B.B.S. from the University of Mysore, India. His research career includes postdoctoral appointments across leading institutions in Germany, France, the United Kingdom, and the United States, where he investigated synaptic plasticity, glutamate neurotransmission, and the molecular mechanisms underlying neurodevelopmental and neurodegenerative disorders. Previously, he served as Global Medical Advisor at Novo Nordisk, contributing to Phase III clinical development programs for Alzheimer's disease. His current research focuses on integrating multimodal biomarkers, genomics, neuroimaging, and artificial intelligence to advance precision neuropsychiatry, healthy aging, dementia screening, and neurodevelopmental disorders such as autism and ADHD. Dr. Halemani has authored and co-authored numerous peer-reviewed publications with more than 600 citations and is an active member of the Society for Neuroscience (SfN), the Federation of European Neuroscience Societies (FENS), and the Medical Affairs Professional Society (MAPS). His work continues to bridge clinical medicine, neuroscience, and AI to develop innovative solutions for neurological and psychiatric healthcare.

T Peterson Wagner is a graduating medical student at the Perelman School of Medicine at the University of Pennsylvania, with clinical and research interests in psychiatry, substance use disorders, interventional psychiatry, psychedelic medicine, and health economics. His recent work focuses on the clinical, economic, and policy implications of ibogaine and related interventions for opioid use disorder, including decision-analytic modeling, QALY-based outcomes, healthcare affordability, and implementation considerations. He is particularly interested in how emerging neuropsychiatric treatments can be evaluated not only for clinical efficacy and safety, but also for cost-effectiveness, scalability, and policy relevance.

Dr. Carolina Duarte Lopes is a professional specializing in digital transformation and healthcare innovation, with a particular focus on clinical information systems, patient pathways, and healthcare service optimization. She holds a Master’s degree in Public Health from the National School of Public Health (NOVA University Lisbon), where her research focused on leadership competencies in public health emergencies. Her professional background combines healthcare management, digital health, strategic communication, and innovation. She has contributed to scientific publications and presented at national and international conferences. Her current interests include digital health, artificial intelligence in healthcare, healthcare innovation, patient-centered care, and the application of emerging technologies to improve clinical practice, including neurological care.

Dr. Andrés Quintero Zea is a Professor of Biomedical Engineering at Universidad EIA in Colombia. He holds a Ph.D. in Electronic Engineering, specializing in neuroengineering, data science, and advanced biomedical signal processing. Dr. Quintero’s research focuses on the intersection of technology and human neuroscience. He specifically uses EEG signal processing, neuroimaging, and machine learning models to decode complex brain dynamics. His recent scientific publications explore the computational modeling of emotional processing within vulnerable populations. Beyond his research, he is a dedicated educator with extensive experience teaching systems analysis, biomedical signal processing, and data analytics for health applications across top Colombian universities.

Dr. Giulia Schembri is a Clinical Psychologist, Family and Systemic Psychotherapist, and international speaker with over 15 years of experience supporting children, adolescents, adults, and families in multicultural and globally mobile environments. She graduated in Clinical Psychology from La Sapienza University of Rome in 2005 and has since built an international career across the United Arab Emirates, France, Australia, the United Kingdom, and Italy. Throughout her professional journey, she has worked extensively with expatriate families, Third Culture Kids (TCKs), and individuals navigating the opportunities and challenges associated with international mobility, cultural transitions, and identity development. Dr Schembri has undertaken specialist training both in Italy and abroad and integrates evidence-based approaches including family therapy, cognitive-behavioural therapy (CBT), EMDR, and psychological support for children, adolescents, and parents. She currently works as a School Counsellor at St George’s British International School in Rome, where she supports the emotional wellbeing of students and families from diverse cultural backgrounds. She is the founder of Growing Up Abroad, a platform dedicated to supporting internationally mobile families and raising awareness of the unique experiences of Third Culture Kids. Through her clinical work, training programmes, workshops, and public speaking engagements, she helps families build resilience, strengthen relationships, and navigate life transitions with confidence. Dr Schembri is the author of Personality Characteristics of Flight Attendants at Emirates Airline, a cross-cultural research project conducted in Dubai involving participants from more than 97 nationalities, and Growing Up Abroad: Risks and Benefits of Third Culture Kids (Crescere all’estero: rischi e vantaggi dei TCK), a book focused on supporting Italian families living abroad and promoting awareness of the developmental needs of globally mobile children. Her work has been presented internationally and continues to contribute to the growing conversation around mental health, cultural identity, family wellbeing, and the experiences of globally mobile communities.

Dr. Sarmistha is a distinguished researcher and professor in the multidisciplinary domain of Humanities and Social Sciences, recognized for her exceptional academic trajectory. She secured top honors as the state topper in Clinical Psychology during her Master's degree and achieved the highest marks in Philosophy across West Bengal in her 12th Board examinations. Continuing her record of academic excellence, she earned top rank during her M.Phil. at Jadavpur University, specializing with high distinction in Cognitive Psychology, as well as Vedanta and Buddhist Philosophy. Her expertise spans a broad range of disciplines, including Neuroscience, Behavioral, Cognitive, Forensic, and Organizational Psychology, as well as Psychoanalysis. In philosophy, her scholar specialization encompasses all nine major schools of Indian Philosophy, Logic, Epistemology, Metaphysics, Ethics, and Indian Scriptures such as the Bhagavad Gita. Her work also integrates Contemporary Thought, Postmodern Ethics—with a specific focus on Jean-François Lyotard—and Environmental Science, Religion, and Society. Dr. Sarmistha’s teaching portfolio includes appointments across multiple colleges at Delhi University and a tenure as an Assistant Professor of General Management at Alliance University. She actively contributes to the scholarly community as a reviewer and key committee member for Kothanak, a multidisciplinary peer-reviewed journal, and is frequently invited as a keynote speaker at national and international conferences. Dedicated to advancing research and practice across her fields, she remains open to collaborative engagements and strategic academic endeavours.

Prof. Mehmet Erkan Ustun is a Professor of Neurosurgery with extensive expertise in vascular and expanded functional neurosurgery. He completed his medical education at Hacettepe University and neurosurgical training at Ankara University. With over 55 SCI-indexed publications and pioneering contributions to novel microsurgical techniques and neurovascular research, his work focuses on restoring neurological function and improving patient outcomes.

Dr. Payam Tamizi is a Mechanical Engineer and Business Leader with over a decade of international experience at the intersection of technology, healthcare, and business innovation. He holds an MBA from the University of Würzburg (Germany) and a Doctorate in Business Administration from the University of Côte d’Azur (France). His current work focuses on Advanced Therapy Medicinal Products (ATMPs), including cell and gene-based therapies and regenerative medicine. Dr. Tamizi has completed professional academic training in Stem Cell Medicine at Harvard Medical School (2025), Parkinson’s disease cell therapy at Harvard Medical School, and Essential and Professional Cell Culture Techniques at the Royan Institute. His career is distinguished by a commitment to translating scientific discovery into investment-ready innovation, fostering growth in high-impact healthcare technologies through strategic leadership, interdisciplinary collaboration, and a global perspective.

Ms. Farah Qureshi is a neuroscientist specialising in brain health, nervous system regulation, and subconscious change. My work integrates qEEG brain mapping, neurofeedback, hypnosis, and neuroscience-based coaching to support measurable and lasting improvements in emotional regulation, cognitive performance, sleep, and resilience. Using data-driven insight alongside trauma-informed approaches, I help clients move beyond symptom management by understanding how their brain functions and how it can be retrained. My approach prioritises safety, regulation, and integration—allowing meaningful change to occur without overwhelm. I work across clinical, performance, and personal development contexts, supporting individuals to restore balance, build self-regulation, and create sustainable change in daily life.

Fábio Aurélio de Moraes is an educational leader with over 15 years of experience in academic management, pedagogical coordination, and consulting for public and private school networks. He holds degrees in Philosophy and Pedagogy, with a specialization in Neuroscience applied to Education. He has worked in institutions such as the Salesian Network, Colégio Franciscano João XXIII, and Instituto Nossa Senhora Auxiliadora, leading projects in curriculum innovation, teacher training, and neuroscience-based educational programs. He is a member of the Confederation of Adolescence and Youth of Ibero-America, Italy, and the Caribbean (CODAJIC Brazil), expanding his participation in international networks of research and educational innovation. Currently, he is pursuing a degree in Psychology (8th semester), integrating psychosocial foundations into his educational practice.

Dr. Husnain Mukhdoom is an award-winning educationist, internationally certified trainer, and academic leader with over a decade of experience in higher education and faculty development. He is the Founder and President of the Famous Forum of Worldwide Collaborators (FFWC LLP), leading initiatives in academic innovation, research, and global education partnerships. He has delivered keynote speeches and training programs in countries including Singapore, New Zealand, Indonesia, Nigeria, and Turkey, reflecting his strong international engagement. Dr. Mukhdoom has served as Principal of STARS Colleges and held roles as Lecturer in English, Academic Advisor, and Coordinator at Aspire Group of Colleges. Holding a Doctorate in Higher Education and TESOL certification, he specializes in faculty training, academic leadership, and institutional development. Recognized globally for his contributions, he continues to support educators and institutions through impactful training and collaboration.

Dr. Barry Hardy is the Chief Executive Officer (CEO) of Edelweiss Connect, Switzerland, where he leads the development of innovative digital solutions for industrial product design, safety assessment, and the translation of advanced research into industrial practice. His current work focuses on next-generation risk assessment, New Approach Methodologies (NAMs), Safer-by-Design strategies, sustainability, and knowledge infrastructure supporting regulatory science. Dr. Hardy is the President of the OpenTox Association, an international non-profit organization dedicated to advancing predictive toxicology, open science, and the principles of the 3Rs (Replacement, Reduction, and Refinement of animal testing). Throughout his career, he has coordinated and led several major European research initiatives, including OpenTox, eNanoMapper, OpenRiskNet, NanoCommons, EU-ToxRisk, and EBiSC, contributing significantly to computational toxicology, bioinformatics, and scientific knowledge management. He earned his Ph.D. in Computational Science from Syracuse University in 1990 and has held prestigious research positions at the U.S. Food and Drug Administration (FDA) and Oxford University. A pioneer in applying web technologies to scientific collaboration, Dr. Hardy has made lasting contributions to computational science, digital innovation, and international research collaboration, with a strong emphasis on advancing safer, evidence-based approaches to healthcare, toxicology, and regulatory decision-making.

Mr. Huawei Zhang is a doctoral candidate in Neurosurgery at Beijing Chao-Yang Hospital, Capital Medical University, under the supervision of Professor Changqing Liu. His research focuses on neuromodulation for post-stroke functional impairment, with particular interests in vagus nerve stimulation, brain–computer interfaces, neurorehabilitation, and population-based neurological disease research. He has published five SCI-indexed articles as first or co-first author in journals including Cancer Letters, Neuroepidemiology, and Brain Sciences. Two of these articles were published in Journal Citation Reports Q1 journals, with a cumulative journal impact factor of 24.1 and a highest individual impact factor of 11.8. His research has focused on the long-term disease burden and future projections of neurological and other major disorders, as well as clinical outcomes in epilepsy-associated brain tumors. Huawei Zhang has contributed as a core research member to projects supported by the National Key Research and Development Program of China, the Natural Science Foundation of Beijing Municipality, and other medical innovation initiatives. His current work includes clinical and translational research on vagus nerve stimulation combined with brain–computer interface-assisted rehabilitation for post-stroke motor recovery. He has delivered oral or poster presentations at international meetings, including the World Congress for Neurorehabilitation, the World Neuroscience Conference, the Asian and Oceanian Epilepsy Congress, and the Asian Epilepsy Surgery Congress. His conference work has also been published in abstract form in journals including Epilepsia. He serves as a peer reviewer for international journals, including CNS Neuroscience & Therapeutics and Neuroepidemiology. He aims to translate epidemiological evidence and neuromodulation research into effective stroke care and rehabilitation.

Farah Ganjei Gron has a degree in Computer Science. She found her calling in 1996 when she attended an introductory talk on homeopathy by the world-renowned homeopath, Dr. Luc De Schepper, M.D. She studied with him for 14 years and wrote her post-fellowship thesis in 2011 on her particular method of using homeopathyto help the children with a diagnosis of autism. In 2009, Dr. De Schepper asked her to became his successor when he retired. In the past 20 years, she has been helping the general population and children on the autism spectrum and others with special needs.

Fatemeh Azarmakan is an interdisciplinary researcher whose work bridges biomedical engineering, clinical psychology, and computational neuroscience. She holds a Bachelor of Science in Biomedical Engineering and a Master of Science in Clinical Psychology from Islamic Azad University (IAU), Tehran, Iran. To further strengthen her foundation in brain science, she completed the MicroBachelors® Program in Neuroscience from Harvard University, where she developed a deeper understanding of the neural mechanisms underlying cognition, emotion, and behavior. Alongside her academic career, Fatemeh is an entrepreneur and the founder of a medical research and innovation company established in 2020. Through this venture, she has collaborated with hospitals, clinicians, pharmaceutical companies, and healthcare organizations on research, technology development, and medical innovation projects. This experience has given her a unique perspective on translating scientific knowledge into practical healthcare solutions while leading multidisciplinary teams. Her current research interests lie at the intersection of affective neuroscience, neurotechnology, brain–computer interfaces (BCIs), and artificial intelligence for mental health. She is particularly interested in developing objective, neuroscience-informed tools that improve emotion regulation and personalize psychological interventions. Her recent work explores EEG biomarkers of cognitive reappraisal and proposes closed-loop BCI systems that provide real-time neurofeedback to support precision mental health. By integrating engineering principles with clinical psychology and neuroscience, Fatemeh aims to advance innovative technologies that bridge basic neuroscience research and clinical practice, ultimately contributing to more personalized and effective treatments for emotional disorders.

Fatima Zahra Nefkhaoui is a clinical psychologist with expertise in cognitive-behavioral therapies and addiction psychiatry. She holds a Bachelor’s degree in Psychology, a Master’s degree in Clinical Psychology, and postgraduate university diplomas in Cognitive Behavioral Therapy (CBT) and Addictology. Her clinical practice focuses on the assessment and treatment of substance use disorders, mood disorders, personality disorders, anxiety disorders, and severe mental illnesses within psychiatric settings. She adopts an integrative, evidence-based approach that combines Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), Emotion-Focused Therapy (EFT), motivational interviewing, and mindfulness-based interventions. Alongside her clinical work, Fatima Zahra is actively engaged in research exploring emotion regulation, self-harm, borderline personality disorder, and addiction. She is the author of an article examining the conceptual links between Stoic philosophy and Cognitive Behavioral Therapy, highlighting the relevance of classical philosophy to contemporary psychotherapeutic practice. She has presented her research at national scientific conferences, including the 26th Annual Congress of the Moroccan Association of Cognitive and Behavioral Therapies (AMTCC), where she presented The Dark Side of Relief: Self-Harm as a Coping Mechanism for Anxiety, and at the CASIPS Scientific Congress, where she delivered a presentation entitled Entre cadre institutionnel et singularité du patient : penser des approches cliniques éthiques et humaines en psychiatrie. Through her clinical, research, and educational activities, she is committed to advancing evidence-based, ethically grounded, and person-centered mental health care.

Hiba Dahmane is a psychomotricity practitioner and researcher from Morocco, with a strong interest in neuroscience, body perception, and psychomotor care in healthcare settings. Her clinical experience includes working with children and adults presenting neurological, developmental, cognitive, and functional difficulties. Her research focuses on the relationship between muscle tone, body perception, and the lived experience of adults with cancer. Her current work, “From the Suffering Body to the Felt Body: Psychomotor Care for Tonic Disorders in Adults with Cancer in a Hospital Setting,” explores the contribution of psychomotor care to hospital-based support and patient well-being.

Dimitri Romanov is a MSc Clinical Neuroscience candidate at the University of Roehampton, where his research bridges molecular neuroscience and theories of consciousness. His current work is a systematic review examining whether microtubules constitute a molecular target of volatile anaesthetics — a question central to quantum-influenced accounts of how anaesthesia suspends conscious awareness. He holds a BSc in Clinical Psychology from London South Bank University, where his dissertation investigated empathy and emotional contagion. His broader interests span neuro-AI, psychopharmacology, and the computational modelling of brain function, and he intends to pursue doctoral research in neuro-AI.

Darlene LaBonte, MBA, is a strategic pharmaceutical and biotech consultant with more than two decades of experience guiding clinical programs from early development through regulatory approval. A Yale‑trained researcher and former clinical operations and quality leader at Regeneron and Eli Lilly, she specializes in integrating operational rigor with regulatory strategy to help organizations accelerate development while maintaining compliance. As Founder of Consults With Darlene, she advises emerging and established biopharma teams on clinical trial execution, operational excellence, and enterprise alignment. Her work spans Phase I–III program oversight, FDA/EMA submissions, risk mitigation, vendor optimization, and cross‑functional leadership support. Darlene’s background includes contributions to translational research at Yale, oversight of complex global studies in industry, and leadership roles interfacing with regulatory authorities. She is recognized for her ability to streamline operations, strengthen team clarity, and move programs efficiently from protocol to patient. She is based in Princeton, NJ, and partners with clients across the United States and Europe.

Hema Sree Nirmal Kumar is a Highly Specialised Intraoperative Physiologist (Neurophysiology) at Oxford University Hospitals NHS Foundation Trust, where she provides specialist intraoperative neurophysiological monitoring and contributes to the development of high-quality neurophysiology services. She is the Secretary of the British Society of Intraoperative Neurophysiology (BSIN), the national professional society representing intraoperative neurophysiology in the UK. In this role, she contributes to the advancement of the specialty and supports professional collaboration and development across the field. Hema has also been awarded funding by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre for a research internship, supporting her continued engagement in research and evidence-based practice. At Oxford University Hospitals, she has played a key role in developing and establishing policies and protocols for intraoperative neurophysiology services, helping to strengthen clinical standards and service delivery. Alongside her clinical and leadership responsibilities, Hema is actively involved in education and professional development at both national and international levels. She has contributed to teaching neurosurgical trainees at Alder Hey Children’s Hospital and Oxford University Hospitals, as well as delivering teaching for the NANSIG group at Imperial College London. She also supports Scientist Training Programme (STP) trainees with their Intraoperative Neurophysiology module. Her professional interests encompass intraoperative neurophysiology, service development, education, research, and the advancement of standards and practice within the specialty.

Professor Adil Ghazali is a teacher-researcher in psychology at Hassan II University of Casablanca. His academic and scientific work falls within the fields of cognitive psychology, neuropsychology, psychometrics, and the assessment of cognitive functions, with a particular interest in adapting psychological tools to the cultural, linguistic, and educational realities of the Moroccan context. Within the framework of this conference, his presentation will focus on the design and standardization of the Moroccan Battery for the Assessment of Cognitive Disorders in Illiterate Individuals, a project aimed at developing a contextualized, valid, and accessible neuropsychological instrument for populations with little or no formal education. This contribution is situated within both a scientific and social perspective, seeking to improve the screening, assessment, and understanding of cognitive disorders in Morocco while taking into account the cultural, linguistic, and socio-educational specificities of the populations concerned.

Oghorodi A. Marvellous is an interdisciplinary biomedical engineer and researcher whose training spans Pharmacology and Biomedical Engineering. He holds a B.Sc. in Pharmacology from Delta State University, Abraka, Nigeria, and an M.Sc. in Biomedical Engineering from the University of Ibadan, Ibadan, Nigeria. His research interests span biomaterials, neuropharmacology, and brain microenvironment engineering. His work integrates pharmacology and experimental research to explore the relationship between biological environments, disease processes, and therapeutic response. His research journey in neuropharmacology has evolved from investigating oxidative imbalance in experimental models of neurodegenerative disease to exploring natural polymer-based systems for targeted drug delivery. His current research drive is focused on understanding disease-associated changes within the brain, particularly elevated reactive oxygen species, and harnessing these changes to develop more targeted and responsive therapeutic approaches for neurodegenerative disorders. His long-term goal is to bridge pharmacology and biomedical engineering in the development of sustainable, intelligent biomaterials, engineered experimental models of pathological conditions, and therapeutic systems that support precision medicine, while advancing locally relevant biomedical solutions for neurodegenerative diseases.

Louis is an MPhil in Foundations of Clinical Psychology student. His research interests consist of adolescent brain development and social cognition, as well as the sociopolitical determinants of mental health. He is particularly interested in how colonialism, political economy, culture, and structural violence shape young people's cognition and behaviour, and in how critical psychological and interdisciplinary approaches can offer meaningful ways of understanding distress, care, and liberation in these contexts. Louis completed a BA Hons. (Cantab.) in Psychological and Behavioural Sciences and is looking to pursue work at the intersection of research, clinical practice, and policy.

Asmaa Elghaichi is an MSc Neuroscience researcher working at the intersection of neuroscience, psychopharmacology, artificial intelligence and neuro-oncology. Her research integrates EEG, ECG, EDA, and virtual reality to investigate neural and autonomic responses to emotional arousal. She is also involved in research on pituitary tumors, extending her work toward brain tumor biology and neuro-oncology. Her broader interests include the application of AI and multimodal neurophysiological data to better understand neurological, psychiatric, and tumor-related disorders.

Idiegbe Success Emuejevoke is an Anatomy graduate with a passion for neuroscience, translational research, medicine, and health policy and management to improve healthcare delivery, reduce health disparities, and influence patient outcomes at both national and global levels. He holds a BSc in Human Anatomy from Babcock University, Nigeria. His early research explores how lead acetate disrupts the hypothalamic Phoenixin-20/NPFFR1 axis and induces neuroendocrine and reproductive dysfunction. Over time, his curiosity has evolved beyond the laboratory to encompass health policy and management, driven by a growing interest in how healthcare systems, governance, and financing can shape equitable access to quality care, improve healthcare outcomes, and address complex healthcare challenges. Driven by a passion for scientific discovery and lifelong learning, Emuejevoke aspires to build a career at the intersection of neuroscience research and medicine. His long-term goal is to become a neuroscientist and surgeon, contributing to advances in neuroscience through impactful research while delivering compassionate, evidence-based patient care. He is particularly interested in neurodegeneration, neuroendocrinology, translational neuroscience, and clinician-led research that bridges the gap between the laboratory and the bedside.

Mr. Prajwal Sharma is a PhD Scholar in the Department of Pharmacology at the Central University of Punjab, Bathinda, India. My doctoral research focuses on developing and evaluating novel therapeutic strategies for Alzheimer’s disease, with particular emphasis on amyloid-β-induced neurotoxicity, cognitive dysfunction, oxidative stress, neuroinflammation, and neuronal and synaptic alterations. My research involves both in vitro and in vivo experimental approaches to investigate the molecular and cellular mechanisms underlying neurodegeneration and to evaluate potential pharmacological interventions. I have experience with cellular models of neurotoxicity, animal models of Alzheimer’s disease, behavioral assessments, biochemical analysis, immunohistochemistry, fluorescence-based imaging, and molecular investigations. My broader research interests include neuropharmacology, neurodegenerative diseases, neuroinflammation, oxidative stress, synaptic plasticity, neuronal signaling, and molecular mechanisms of neuroprotection. I am particularly interested in understanding how restoration of cellular homeostasis and modulation of pathological pathways can contribute to cognitive recovery and therapeutic development in neurodegenerative disorders. During my doctoral training, I have also been involved in scientific writing, research publications, book chapters, and presentations at national and international scientific conferences. These experiences have helped me develop an interdisciplinary approach integrating pharmacology, neuroscience, molecular biology, and experimental therapeutics. Through my research, I aim to contribute to a better understanding of the mechanisms involved in Alzheimer’s disease and to identify promising, mechanism-based therapeutic approaches. My long-term research interests are directed toward translational neuroscience and the development of innovative pharmacological strategies for neurodegenerative disorders.

Dr. Arshia Vahedi, M.D., is a medical doctor and neuroscience researcher specializing in computational neuroscience, brain functional connectivity, cognition, memory, and neurodegenerative diseases. His research uses EEG, fMRI, signal processing, machine learning, and deep learning to investigate brain function and neurological disorders. He is also the Founder and Director of the Online Neuroscience Network Research Center (ONNRC), promoting collaborative neuroscience research.

Kaylie Van Beek offers a unique, experience-driven perspective on neurodivergence and its connection to physical health. For over 35 years, she has navigated complex personal experiences often misunderstood as a lack of attention, while in reality maintaining a heightened awareness of her surroundings and internal responses. Beginning at age 18, she received multiple diagnoses but found limited clarity through conventional pathways. Through independent research and pattern recognition, she identified herself as both hypermobile and neurodivergent. This led her to explore the intersection of connective tissue disorders, autonomic dysfunction, and neurodivergence, where she recognized similar undiagnosed patterns across four generations of her family. Her journey, initially driven by the need to understand her own health and that of her son, evolved into a conceptual framework she calls “Psychosomatic Profiling.” This approach suggests that certain behaviors commonly labeled as ADHD, autism, or mental illness may reflect physical adaptations to underlying structural and autonomic conditions. While she does not hold a formal medical degree, Kaylie contributes a powerful lived perspective grounded in decades of observation, documentation, and real-life data—aimed at fostering awareness, early recognition, and meaningful dialogue in neuroscience.

T. Naveen Keerthi is a final-year MBBS student at MIMER Medical College, Maharashtra University of Health Sciences (MUHS), India, with research interests spanning computational neuroscience, neuroimaging, artificial intelligence, mathematical modeling, and translational medicine. He is the Founder and Research Lead of NeuroHawk, an AI-powered platform for the early detection of Amyotrophic Lateral Sclerosis (ALS) using diffusion tensor imaging biomarkers and predictive machine learning models. His research focuses on developing computational approaches that bridge neuroscience and clinical decision-making. Naveen has completed research and clinical observerships at the University of Kansas Medical Center across psychiatry, precision psychiatry, orthopedic surgery, radiomics, pulmonary hypertension, nephrology, and molecular biology. He has also contributed to research at ACTREC–Tata Memorial Centre, Tata Memorial Hospital, the National Brain Research Centre (NBRC), IIT Madras, IIT Bhubaneswar, and The Neurosurgical Atlas, working on projects spanning neuroscience, oncology, neurotechnology, and computational medicine. A Gold Medalist and State Topper in Pathology at MUHS, Naveen serves as a peer reviewer for multiple international biomedical journals and holds leadership roles in several student research organizations. His work has been presented at national and international conferences, reflecting his commitment to advancing precision neuroscience through interdisciplinary research and innovation.

Mr. Zhi Zhang is a postgraduate student majoring in Neurosurgery at Capital Medical University. Under the supervision of Professor Yang Wang, the author focuses on translational research of glioma tumor microenvironment and glioma immunotherapy. His current research centers on cancer-associated fibroblasts (CAFs), a vital stromal component in glioma microenvironment, especially exploring how CAF subpopulations remodel immunosuppressive niche and mediate immunotherapy resistance.In his master’s project, he combines primary cell isolation, proteomic screening, lentiviral gene modification, macrophage polarization models and multiple molecular biological assays to dissect the regulatory function of CD166-positive CAFs. He aims to clarify the NF-κB-dependent signaling cascade by which CD166+ CAFs drive M2 macrophage polarization and facilitate glioma immune evasion.He has mastered primary CAFs culture, RT-qPCR, Western blotting, immunofluorescence, Transwell and CCK-8 functional assays. He is familiar with proteomic data analysis, KEGG enrichment and in vitro immune co-culture systems. He has participated in laboratory routine management, specimen collection and collaborative experiments. His research is expected to uncover a novel CAF-related mechanism and offer potential targets to reverse glioma immunosuppression.His academic interests include stromal cell heterogeneity, intercellular paracrine crosstalk and macrophage polarization in central nervous system tumors. He hopes to translate basic findings into actionable strategies to improve the efficacy of glioma immunotherapy.

Abakar HAGGAR, PhD student-Researcher, in clinical neurology, at the Laboratory of Clinical Neurosciences, Faculty of Medicine and Pharmacy-Fez, Morocco. My main interests are on neurodegenerative diseases Parkinson's disease, Alzheimer's disease in application to MRI techniques, VBM, and statistical analysis by SPM, CAT12 and Python.

Ify Nwiwu is a qualified and accomplished Registered Nurse, holding both RNLD and RGN registrations. She is a PhD researcher at the University of Wolverhampton, where her work focuses on the lived experiences and healthcare implications of Female Genital Mutilation (FGM) and Breast Ironing (BI). Ify graduated with a First-Class degree in Learning Disability Nursing and later completed a master’s degree in Adult Nursing, both from the University of Wolverhampton. She is a multi-award-winning researcher, recognised at several national and international academic conferences for her work on FGM and BI. These accolades include recognition from institutions such as the University of Cambridge, Leeds Beckett University, and the University of Wolverhampton, among others. In addition, Ify has published a number of articles focusing on women’s health, women’s rights, cultural practices, and advocacy for vulnerable and marginalised groups. With a diverse professional background, Ify has worked extensively within the NHS as a Health Facilitation Nurse and a Mental Health Practitioner with CAMHS, as well as in the private healthcare sector. Her clinical, academic, and leadership experience informs her holistic and person-centred approach to care. Ify is currently a Lecturer in Learning Disability Nursing at the faculty of Health Sciences and Wellbeing at the University of Sunderland in London. She is deeply committed to advocacy for women and vulnerable children, using her own lived experience to inspire and empower others. Having pursued her education as an adult learner, she is particularly passionate about encouraging women to return to education, build confidence, and develop the skills to advocate for themselves and their communities. Her work reflects a strong commitment to social justice, equality in healthcare, and the advancement of culturally competent, trauma-informed practice.

Dr. Wajiha Shahid is a PhD, a clinical physiotherapist and researcher specializing in neuromuscular and pediatric neurorehabilitation. I hold a PhD in Rehabilitation Sciences from Riphah International University, Pakistan, and have over a decade of clinical and academic experience. I currently serve as a Clinical Physical Therapist in the Pediatric Neurology Department at The Children’s Hospital, University of Child Health Sciences, Lahore, and as an Associate Professor at Superior University, Lahore, Pakistan. My research interests include neurological rehabilitation, motor function recovery, exercise-based interventions, stroke, cerebral palsy, and technology-assisted rehabilitation. I have published research in peer-reviewed journals, including Scientific Reports and BMC Women’s Health, and have presented my work at national and international scientific conferences. Moreover. I am an Academic Editor of PLOS ONE and Editor In chief of Physio Plus open Journal.

Rudra Pankajkumar Trivedi is an MBBS intern and clinical researcher at GMERS Medical College & Hospital, Gotri, Vadodara, India, with a primary academic and career interest in Internal Medicine. His research interests also encompass neurology, cardiology and evidence-based medicine. He has contributed to multiple peer-reviewed publications, clinical case reports, systematic reviews and meta-analyses, including research involving neurological disorders and CAR-T cell therapy-associated neurotoxicity. He has presented scientific work at national conferences and serves as Chief Lead and Organizer of the Research Club at GMERS Gotri, a student research community involving more than 160 medical students. His broader interests include clinical research, scientific writing and the investigation of unusual and diagnostically challenging clinical presentations.

Neha Yadav is a Research Scholar in the Department of Biochemistry, Institute of Science, Banaras Hindu University (BHU), Varanasi, India, working under the supervision of Prof. S. Srikrishna. She qualified CSIR-UGC NET-JRF in 2022 and has approximately five years of experience in biomedical and neuroscience research. Before pursuing her doctoral studies, she spent one year investigating Alzheimer’s disease, which contributed to her interest in neurodegenerative disorders. Her doctoral work focuses on the molecular and cellular consequences of traumatic brain injury (TBI) using Drosophila melanogaster and mouse models. Her expertise includes behavioral assays, molecular biology, biochemical analysis, immunohistochemistry, fluorescence and confocal microscopy, and the assessment of neuronal, oxidative, mitochondrial, and cellular changes. Her work integrates behavioral, molecular, imaging, and proteomic approaches to investigate neuroinflammation, oxidative stress, mitochondrial dysfunction, neuronal injury, and impaired neurogenesis following TBI. She aims to elucidate mechanisms underlying secondary brain injury and identify molecular pathways with potential relevance to neurodegenerative disorders.

Dr. Saad Chraïbi is a licensed Psychomotrician based in Casablanca, Morocco. He graduated in 2021 from the Mohammed VI University of Health Sciences (UM6SS), where he specialized in psychomotricity. He currently practices in a private clinical setting, providing assessment and therapeutic interventions to individuals across various age groups. Prior to pursuing psychomotricity, Mr. Chraïbi completed four years of medical education, including three years at Iva Mar Diop Saint Christopher Medical School in Dakar, Senegal, and one year at the Darhavina State Institute in Tambov, Russia. This multidisciplinary academic background has provided him with a strong foundation in medical sciences, complementing his expertise in psychomotor therapy. His professional interests include the integration of medical knowledge with psychomotor rehabilitation, promoting holistic approaches to patient care and enhancing physical, cognitive, and emotional well-being.